Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan.
Fukano R, Mori T, Kobayashi R, Mitsui T, Fujita N, Iwasaki F, Suzumiya J, Chin M, Goto H, Takahashi Y, Hara J, Park YD, Inoue M, Koga Y, Inagaki J, Sakamaki H, Adachi S, Kawa K, Kato K, Suzuki R. Fukano R, et al. Among authors: sakamaki h. Br J Haematol. 2015 Feb;168(4):557-63. doi: 10.1111/bjh.13167. Epub 2014 Oct 14. Br J Haematol. 2015. PMID: 25312752 Free article.
The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K, Ishikawa Y, Kato S, Sao H, Sakamaki H, Kawa K, Hamajima N, Asano S, Kodera Y. Morishima Y, et al. Among authors: sakamaki h. Blood. 2002 Jun 1;99(11):4200-6. doi: 10.1182/blood.v99.11.4200. Blood. 2002. PMID: 12010826 Free article.
Nonmyeloablative stem cell transplantation with fludarabine and cyclophosphamide for patients with hematologic malignancies.
Nakajima H, Oki M, Kishi K, Ueyama J, Miyakoshi S, Hatsumi N, Sakura T, Miyawaki S, Yokota A, Fujisawa S, Mori S, Tanaka Y, Sakamaki H; Kanto Study Group for Cell Therapy. Nakajima H, et al. Among authors: sakamaki h. Clin Lab Haematol. 2003 Dec;25(6):383-91. doi: 10.1046/j.0141-9854.2003.00550.x. Clin Lab Haematol. 2003. PMID: 14641143 Clinical Trial.
Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.
Kanda Y, Izutsu K, Hirai H, Sakamaki H, Iseki T, Kodera Y, Okamoto S, Mitsui H, Iwato K, Hirabayashi N, Furukawa T, Maruta A, Kasai M, Atsuta Y, Hamajima N, Hiraoka A, Kawa K. Kanda Y, et al. Among authors: sakamaki h. Leukemia. 2004 May;18(5):1013-9. doi: 10.1038/sj.leu.2403343. Leukemia. 2004. PMID: 15029208
Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation.
Ogawa H, Ikegame K, Kawakami M, Takahashi S, Sakamaki H, Karasuno T, Sao H, Kodera Y, Hirabayashi N, Okamoto S, Harada M, Iwato K, Maruta A, Tanimoto M, Kawa K; Japan Society for Hematopoietic Cell Transplantation. Ogawa H, et al. Among authors: sakamaki h. Int J Hematol. 2004 Jun;79(5):495-500. doi: 10.1532/ijh97.03166. Int J Hematol. 2004. PMID: 15239403
Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen.
Kojima R, Kami M, Nannya Y, Kusumi E, Sakai M, Tanaka Y, Kanda Y, Mori S, Chiba S, Miyakoshi S, Tajima K, Hirai H, Taniguchi S, Sakamaki H, Takaue Y. Kojima R, et al. Among authors: sakamaki h. Biol Blood Marrow Transplant. 2004 Sep;10(9):645-52. doi: 10.1016/j.bbmt.2004.06.003. Biol Blood Marrow Transplant. 2004. PMID: 15319776 Free article.
Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years.
Kojima R, Kami M, Kanda Y, Kusumi E, Kishi Y, Tanaka Y, Yoshioka S, Morishima S, Fujisawa S, Mori SI, Kasai M, Hatanaka K, Tajima K, Kasai M, Mitani K, Ichinohe T, Hirai H, Taniguchi S, Sakamaki H, Harada M, Takaue Y. Kojima R, et al. Among authors: sakamaki h. Bone Marrow Transplant. 2005 Oct;36(8):667-74. doi: 10.1038/sj.bmt.1705122. Bone Marrow Transplant. 2005. PMID: 16113674
Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S, Nakaseko C, Nishimura M, Maruta A, Cho R, Ohwada C, Sakamaki H, Sao H, Mori S, Okamoto S, Miyamura K, Kato S, Kawase T, Morishima Y, Kodera Y; Japan Marrow Donor Program. Ozawa S, et al. Among authors: sakamaki h. Br J Haematol. 2007 Apr;137(2):142-51. doi: 10.1111/j.1365-2141.2007.06543.x. Br J Haematol. 2007. PMID: 17391494 Free article.
501 results